Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Comprehensive Loss

v3.2.0.727
Consolidated Statements of Comprehensive Loss - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Operating costs and expenses:        
Research and development $ (555,740) $ (1,032,681) $ (1,590,823) $ (1,597,571)
General and administrative (803,399) (1,607,210) (1,738,625) (4,001,415)
Loss from operations (1,359,139) (2,639,891) (3,329,448) (5,598,986)
Other income (expense):        
Loss on disposal of subsidiaries 0 0 0 (1,069,675)
Other income (expense) 234,453 (128,186) (225,515) (162,607)
Interest income 914 10,698 1,088 11,742
Interest expense (1,386) (1,489) (2,512) (2,373)
Total other income (expense) 233,981 (118,977) (226,939) (1,222,913)
Loss before income taxes (1,125,158) (2,758,868) (3,556,387) (6,821,899)
Income tax 0 0 0 0
Net loss (1,125,158) (2,758,868) (3,556,387) (6,821,899)
Other comprehensive income (loss) from foreign currency translation adjustment (338,875) 397,760 (327,054) 523,641
Total comprehensive loss $ (1,464,033) $ (2,361,108) $ (3,883,441) $ (6,298,258)
Net loss per share of common stock, basic and diluted $ (.01) $ (.02) $ (.03) $ (.05)
Weighted-average shares of common stock outstanding, basic and diluted 139,297,282 136,052,498 139,297,282 134,087,670